Addressing Unmet Needs in Alzheimer Disease: Implications of Delayed Diagnosis and Examining New and Emerging Therapies

Contact Hours : 2.5
Start Date :  Aug 07, 2020End Date :  Aug 07, 2021

Duration :  150 Minutes

Organized by :   Pharmacy Times Continuing Education (PTCE)

Specialties :   Neurology

Fees Fee :   Starting From Free

Conference Summary

Addressing Unmet Needs in Alzheimer Disease: Implications of Delayed Diagnosis and Examining New and Emerging Therapies is organized by Pharmacy Times Continuing Education (PTCE).

Release date: August 7, 2020
Expiration date: August 7, 2021

Accreditation:
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.5 contact hour (0.25 CEU) 

Program Description:
Alzheimer disease (AD) is the sixth leading cause of death and the most common etiology for dementia. The progressive and neurodegenerative nature of AD causes a significant burden to the public health system, patients afflicted with it, and their caregivers. Continuing professional education will increase managed care professionals’ competency on AD including the importance of early detection, patient and caregiver education, and the role of new therapeutic targets for the treatment of AD. Application of knowledge will improve clinical decision making, improve quality of life among patients and caregivers, optimize medication therapy, improve outcomes, and decrease costs associated with the treatment of AD.

Educational Objectives
At the completion of this activity, the participant will be able to:

• Explore the impact of Alzheimer disease as it relates to progression, value of early diagnosis, associated comorbidities, and effect on patients and caregivers.
• Analyze current and emerging data for new therapeutic targets for the pharmacologic treatment of Alzheimer disease.
• Examine the importance of medication therapy management and drug utilization reviews for controlling costs and improving outcomes among patients with Alzheimer disease.

Topic
✔Dementia
  Dementia
Credit Info

  • Contact Hours : 2.5
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat
Recommended